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Abstract: General anaesthesia for obstetric surgery has distinct characteristics, which may
contribute towards a higher risk of accidental awareness during general anaesthesia.
The primary aim of this study was to investigate the incidence, experience and
psychological implications of unintended conscious awareness during general
anaesthesia in obstetric patients. From May 2017 to August 2018, 3115 consenting
patients receiving general anaesthesia for obstetric surgery in 72 hospitals in England
were recruited. Patients received three repetitions of standardised questioning over 30
days, with responses indicating memories during general anaesthesia verified using
interviews and record interrogation. A total of 12 patients had certain/probable or
possible awareness; an incidence of 1 in 256 (95%CI 1 in 149 – 1 in 500) for all
obstetric surgery. The incidence was 1 in 212 (95%CI 1 in 122 – 1 in 417) for
caesarean section surgery. Distressing experiences were reported by seven (58.3%)
patients; paralysis by five (41.7%), paralysis with pain by two (16.7%) reported.
Accidental awareness occurred during induction and emergence in nine (75%)
patients. Factors associated with AAGA were high BMI (25-30 kg.m  -2  ), low BMI
(<18.5 kg.m  -2  ), out-of-hours surgery and use of ketamine or thiopental for induction.
Standardised psychological impact scores at 30 days were significantly higher in
awareness patients (median (IQR [range]): 15 (2.75 – 52 [2 – 56]) than in patients
without awareness: 3 (1 – 9 [0 – 64]; p = 0.010). Four patients had a provisional
diagnosis of post-traumatic stress disorder. We conclude that direct postoperative
questioning reveals high rates of accidental awareness during general anaesthesia for
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obstetric surgery, which has implications for anaesthetic practice, consent and follow-
up.
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Summary 
General anaesthesia for obstetric surgery has distinct characteristics, which may contribute towards 
a higher risk of accidental awareness during general anaesthesia. The primary aim of this study was 
to investigate the incidence, experience and psychological implications of unintended conscious 
awareness during general anaesthesia in obstetric patients. From May 2017 to August 2018, 3115 
consenting patients receiving general anaesthesia for obstetric surgery in 72 hospitals in England 
were recruited. Patients received three repetitions of standardised questioning over 30 days, with 
responses indicating memories during general anaesthesia verified using interviews and record 
interrogation. A total of 12 patients had certain/probable or possible awareness; an incidence of 1 in 
256 (95%CI 1 in 149 – 1 in 500) for all obstetric surgery. The incidence was 1 in 212 (95%CI 1 in 122 – 
1 in 417) for caesarean section surgery. Distressing experiences were reported by seven (58.3%) 
patients; paralysis by five (41.7%), paralysis with pain by two (16.7%) reported. Accidental 
awareness occurred during induction and emergence in nine (75%) patients. Factors associated with 
AAGA were high BMI (25-30 kg.m-2), low BMI (<18.5 kg.m-2), out-of-hours surgery and use of 
ketamine or thiopental for induction. Standardised psychological impact scores at 30 days were 
significantly higher in awareness patients (median (IQR [range]): 15 (2.75 – 52 [2 – 56]) than in 
patients without awareness: 3 (1 – 9 [0 – 64]; p = 0.010). Four patients had a provisional diagnosis of 
post-traumatic stress disorder. We conclude that direct postoperative questioning reveals high rates 
of accidental awareness during general anaesthesia for obstetric surgery, which has implications for 
anaesthetic practice, consent and follow-up. 
 
 
  
 
 
Background 
The incidence of accidental awareness during general anaesthesia (AAGA) may be influenced by 
patient characteristics, but also by the methods used to ascertain it. At one extreme, studies based 
on spontaneous reporting by patients find a very low incidence [1]. The largest study using this 
methodology – the 5th National Audit Project in the UK and Ireland (NAP5) – reported an average 
incidence of 1 in 19000, rising to 1 in 8000 when neuromuscular blocking (NMB) drugs are used [2]. 
In contrast, studies involving questioning patients directly about their memories of the 
intraoperative period (typically using a short series of questions termed the ‘Brice’ interview, which 
enquire about memories from immediately before, during and after general anaesthesia [3]) 
consistently report incidences of 1-2 per 1000 (averaging 1 in 600) [4-10]. Direct questioning tends 
to identify the highest incidence when the Brice questions are repeated three times over a month 
[9,11] (the ‘thrice Brice’ method). 
The reasons for these differences in incidence are variously attributed. One interpretation is under-
reporting, either because patients are distressed by AAGA and disinclined or not given the 
opportunity to make a report, or because patient reports are not considered credible or not 
escalated. Conversely, the Brice interview may not be sufficiently precise as to distinguish true AAGA 
from other memories and there is consensus that it is probably over-sensitive as a tool: its results 
require further consideration of the details of the case to establish whether a report represents 
AAGA or not [12]. 
One of the striking results of NAP5, was the relatively high incidence of AAGA in obstetric patients, 
at 1 in 1200, or 1 in 670 for caesarean section (CS) delivery. This latter estimate is notable for being 
very similar to the incidences cited using Brice interviews for non-obstetric surgery. For obstetric 
surgery, the incidence of AAGA detected by Brice interviews is between 1 in 110 and 1 in 152 but 
these estimates come from studies that are somewhat dated in terms of anaesthetic practice [13,14] 
and have not triangulated Brice responses against anaesthetic records and detailed patient reports 
in the way NAP5 did. Obstetric general anaesthesia for CS involves multiple risk factors for AAGA, 
including the nearly universal use of NMB drugs and rapid sequence induction, alongside a high 
incidence of difficult airway management and emergency or out of hours surgery [15]. It is unclear 
whether estimated differences in AAGA incidences between obstetric and non-obstetric surgery can 
be accounted for solely due to the combination of risk factors, or what the impact of detection 
methodology is [14], or whether other pregnancy-specific characteristics increase the risk further. 
 
 
The aim of the Direct Reporting of Awareness in Maternity patients (DREAMY) study was to describe 
the epidemiology of AAGA and its consequences in adult patients undergoing obstetric surgery. The 
study aimed to describe the incidence (detected via direct questioning), nature of experiences, risk 
factors and psychological implications of AAGA. The specific hypothesis was that the incidence of 
AAGA detected with direct questioning would be higher in obstetric surgery compared with non-
obstetric surgery, as was found with patient-initiated reporting in NAP5. 
 
Methods 
Research Ethics Committee (17/LO/0071) and Health Research Authority approvals were granted, 
alongside prospective registration of the trial aims (ClinicalTrials.gov Identifier: NCT03100396). Full 
details of the study protocol are available separately [16], and we provide salient details in brief 
below. Participants provided written informed consent for the study after their surgery. 
Participants were aged 18 years or older, who underwent obstetric surgery under general 
anaesthesia in public healthcare sector hospitals in England. General anaesthesia was administered 
according to local institutional practice. Patients were excluded if the date of surgery was at <24 
weeks gestation or ≥48 hours postpartum, or if surgery was for a non-obstetric indication during 
pregnancy. Only patients able to communicate in English were included. 
A two-phase approach was initially used to assess whether AAGA had occurred. During the first 
phase, three repetitions of Brice screening interviews were conducted; the first within 24 hours 
following extubation, then between 24 and 48 hours, and at 30 days after surgery. During the 
second phase a verification semi-structured telephone interview was conducted by the study lead 
[PO] with all participants who indicated recall of events attributed to the period between ‘‘going to 
sleep” and ‘‘waking up”. This interview was conducted as soon as possible following patient 
reporting. Any specific description of events made in verification interviews, including the timing and 
nature of reported sensory perceptions, was investigated with clinical teams and case records to 
establish corroboration or refutation. 
Patients reporting suspected intraoperative recall were followed up for 12 months, with further 
semi-structured telephone interviews and a self-report symptom measure for post-traumatic stress 
disorder (PTSD) administered at day 30, then at three, six, nine and 12 months – the PTSD Checklist 
for DSM-5 (PCL-5) [17]. In addition, patients were asked to report diagnoses and risk factors 
 
 
associated with PTSD in the post-natal period, including postpartum depression [18]. A comparator 
sample of at least 300 patients with no intraoperative recall provided PCL-5 responses at day 30 
only. All patients were offered best-practice supportive care in accordance with the NAP5 
Anaesthesia Awareness Support Pack guidelines [19]. 
Researchers collected a detailed, standardised dataset from patients and their medical records, 
including characteristics of general anaesthesia and airway management, alongside workforce, 
timing and surgical parameters [16]. 
After all participants had completed the study, a panel of five authors [PO, SB, NL, JA, JP] reviewed 
all participant reports, interview transcripts and anaesthetic data. Assessors were blinded to hospital 
site and patient identifiers. Panel members collectively discussed each case, and their declared 
adjudication decisions were assessed using Fleiss’s  statistic to measure agreement. Detail, 
plausibility and consistency of reported experiences with the intra-operative process were 
considered. All cases were then reviewed a second time by the same group of assessors on a 
different date, to reach a final adjudication decision on each case, determined by majority. Reports 
were graded using the same schematic as for NAP5: as “certain/probable”, “possible”, “unlikely” or 
“none”. Reports were classified accordingly to pre-declared structures, including sensory experience 
(the Michigan Awareness Classification Instrument), measure of psychological harm (a modified 
National Patient Safety Agency tool, revised for use in NAP5) and the phase of anaesthesia that 
AAGA was judged likely to have occurred during (i.e. induction, during maintenance of anaesthesia 
or emergence). Reports of dreaming during general anaesthesia, but with no evidence of AAGA, 
were graded according to whether specific memories of the dream content were present, and 
whether such content was pleasant, neutral or unpleasant. 
The primary outcome was the proportion of obstetric patients reporting a composite of 
certain/probable and possible AAGA. This composite outcome reflects patient-centric reporting 
considerations and provides consistency with NAP5 [20]. 
A minimum sample size of 2015 patients was estimated, based an exact binomial test with power of 
80% and alpha of 0.05 to detect an incidence of AAGA that was at least three times higher than a 
comparator baseline in non-obstetric surgical patients, taken as 0.15% [4,5,8,9,21]. Given expected 
imprecision in estimates for the binomial proportions with rare events, recruitment was planned to 
exceed this minimum estimate thereby improving confidence intervals for estimation of prevalence. 
The chi-square test, Fisher’s exact test, an unpaired t-test, and an unpaired Mann–Whitney test 
were used for other comparisons between groups. 
 
 
PTSD was evaluated using the PCL-5 instrument [17]. Any symptom rated as ‘moderately’ or higher 
was considered positive; patients were considered to have screened positive for PTSD if responses 
from a single follow up interval included at least: one ‘positive’ B (intrusion symptoms) item 
(questions 1-5), one C (avoidance symptoms) item (questions 6-7), two D (negative alterations of 
cognitions and mood) items (questions 8-14), two E (alterations in arousal and reactivity) items 
(questions 15-20). 
Independent associations with AAGA and PTSD outcomes were explored using binary logistic 
regression and multiple imputation analyses. Suspected predictors of AAGA (age, urgency of surgery, 
ASA, body mass index (BMI) and timing of surgery) were entered into a stepwise regression model, 
alongside variables for anaesthetic characteristics (induction drugs, seniority of attending 
anaesthetist). PTSD associations were entered as self-declared maternal mental health conditions, 
which were defined as discrete binary variables (previous medical history of depression, anxiety 
disorder or PTSD). Ordinal variables were defined for neonate birth weight, and Likert scale 
responses on maternal perceptions of support from healthcare providers or family members. Pre-
term neonates were defined as those born at <37 weeks gestation. The proportion of patients with 
missing data for any covariate included in the multivariable models ranged from 0% to 4.17%. 
Characteristics of the patients with full data were similar to those with missing data, hence a missing 
at random assumption was used to impute missing data. The regression model results are presented 
with the imputed data and as adjusted odds ratios. 
 
 
  
 
 
Results 
A total of 72 hospitals in England recruited patients to the study between May 2017 and August 
2018. A total of 3115 patients provided written informed consent for inclusion following eligibility 
screening of 4969 patients (Figure 1). All 3115 patients completed at least one screening Brice 
interview and were included in the primary outcome analysis; 2937 (94.3%) completed two 
interviews and 1808 (58.0%) completed all three interviews. Table 1 shows the baseline 
characteristics of participants. 
During at least one screening Brice interview, 266 (8.5%) patients reported memories they 
attributed to the period between “going to sleep” and “waking up” at the end of surgery (Figure 1 
and Table 2). All these patients underwent further verification or interviews. The most commonly 
reported types of memories were of dreaming during anaesthesia, by 167 patients (62.8% of the 
266); or hearing voices, by 96 patients (36.1%); or anxiety, by 31 patients (11.7%). 
Verification of initial responses demonstrated the majority of memories, reported by 238 patients 
(89.4%), were evidently not AAGA events; instead representing memories of an unrelated dream 
(which may have occurred during or after general anaesthesia), planned awake extubation, 
misunderstanding of the Brice questions (e.g. reporting memories of the anaesthetist speaking 
during the initial process of induction of general anaesthesia) or reports that clearly did not 
represent intraoperative events (e.g. feeling initial application of cricoid pressure, or being unable to 
move lower limbs after a spinal neuraxial block but before general anaesthesia). 
Of the remaining 28 (0.8%), patients with suspected AAGA, six patients were determined by the 
adjudicating panel as having unlikely AAGA; all these experiences consisted of reports that the 
patients considered to be intraoperative memories, but in which detail could not be established 
during verification interviews, or in which there was reasonable likelihood that the episode occurred 
outside the period of anaesthesia. A further four patients described an awareness experience during 
non-general anaesthetic circumstances: two experiences were associated with suspected total spinal 
anaesthesia, and two patients reported wakefulness during sedation whilst on the intensive care 
unit postoperatively. Finally, a further six patients described responses lacking detail in the Brice 
interviews that might represent AAGA, but further follow up was declined or verification of the Brice 
responses was not possible. 
This left 12 patients whom the adjudication panel determined had certain/probable (seven) or 
possible (five) AAGA (Table 2); an estimated prevalence of 0.39% (95% CI 0.20 – 0.67) or 1 in 256 
 
 
(95% CI 1 in 149 – 1 in 500). Grading of the AAGA events according to the Michigan Awareness 
Classification Instrument is provided in Table 3, alongside characteristics of the surgical and general 
anaesthesia procedures undertaken for each participant. This estimated prevalence of AAGA is 
significantly higher than reported in previous large cohort studies of AAGA in non-obstetric surgical 
patients (p = 0.010)[4,5] and is higher than following spontaneous reporting in obstetric by NAP5 (p 
= 0.001) [2]. 
In this cohort of 12 patients, AAGA was first detected on the initial screening interview at <24 hours 
postoperatively for 11 patients and at the second interview (24-48 hours postoperatively) for one 
patient. However, it was apparent during the verification interviews that this latter patient (ID 1), 
had recall of events following emergence but chose not to share these during her first Brice 
interview (abbreviated details of which are provided in Table 4; full details are in Supplementary 
materials Table S1). Of the 11 patients first detected at initial screening interview, two had already 
made a report of AAGA spontaneously to recovery nursing staff and a further five had spontaneously 
reported their experiences to relatives or partners. Thus, over half, seven of 12 (58.3%), in fact made 
a spontaneous report, and no additional patients were detected by repeating the Brice 
questionnaire. A total of nine patients completed 12 months of follow up; two patients withdrew 
from study follow up at 30 days following surgery, one withdrew at three months. 
All patients with certain/probable or possible AAGA underwent CS (CS represented 2554 (81.9%) of 
all surgical procedures), and all received NMB drugs. The risk of AAGA after CS in our study is 
therefore 0.47% (95% CI 0.24 – 0.82) or 1 in 212 (95% CI 1 in 122 – 1 in 417). The degree of surgical 
urgency was Category 1 for only three (25.0%) patients, despite this category accounting for 52.0% 
of all CS surgery. One participant reported AAGA during an elective CS; the remainder were during 
Category 2 CS. Detailed analysis of baseline general anaesthesia characteristics and airway 
management techniques for the whole cohort are reported separately [15].  
AAGA occurred during the dynamic phases of anaesthesia for nine (75%) patients; five at induction 
and four during emergence. Of the five patients reporting AAGA during induction a potentially 
insufficient hypnotic drug dose (<4.0mg.kg-1 thiopental or <2.0mg.kg-1 propofol respectively) was 
administered to two patients; one of which also involved management of an unpredicted difficult 
tracheal intubation. The remaining three patients reported tactile sensations that may have 
occurred due to anaesthetic or surgical manipulation before adequate anaesthetic depth was 
achieved. 
 
 
Two patients experienced residual paralysis during emergence (16.7%); one of which occurred 
following administration of suxamethonium to a patient with previously undiagnosed abnormally 
reduced plasma cholinesterase function; the second being secondary to incompletely reversed 
neuromuscular blockade with rocuronium (neostigmine followed by sugammadex were 
administered sequentially during emergence). Neither patient received nerve stimulator monitoring 
before the AAGA event. The remaining two patients with emergence AAGA described less detailed 
accounts of events. 
Two patients (16.7%) reported AAGA during the maintenance phase of anaesthesia. Both patients 
received suxamethonium as the NMB drug for tracheal intubation, but no further doses of NMB 
drug. One of these had low end-tidal anaesthetic agent concentrations (with no nitrous oxide) 
during the maintenance phase (estimated age-adjusted minimum alveolar median concentration of 
0.7, high of 0.8 and low of 0.5); the other had a high BMI (43kg.m-2).  
Conduct of anaesthesia differed in several respects between patients reporting AAGA and no AAGA 
(Figure 2). Propofol was under-represented in the AAGA group (p = 0.045), being used in only two 
patients (16.7%), compared with 1417 (45.5%) in the baseline group. Conversely, thiopental was 
used in nine patients (75.0%), compared with 1640 (52.9%) in the baseline group (p = 0.121). Opioid 
use during induction of GA was lower in the AAGA group, at four (33.3%) patients, but this was not 
significantly different (p = 0.486) when compared with the 1347 (43.4%) patients in the baseline 
group who received opioids. All AAGA patients received NMB drugs. Non-depolarising NMB use was 
similar in the AAGA group to the baseline, received by seven of 12 (58.3%), compared with 1620 of 
3115 (52.0%) (p = 0.661). Five of the AAGA patients received suxamethonium, but no non-
depolarising NMB drug (41.7%). Nerve stimulator use was influenced by the complications during 
emergence in the AAGA group, since monitoring was only applied after residual paralysis was 
clinically recognised (and AAGA had occurred) in two patients. Four of the remaining 12 AAGA 
patients (33.3%) received nerve stimulator monitoring, compared with use by 855 of all 3115 
patients in the baseline cohort (27.4%). Use of nitrous oxide and sevoflurane was similar across the 
groups. 
Ten patients with AAGA (83.3%) underwent surgery during the night shift (20:00 – 07:59); a far 
greater proportion compared with the non-AAGA cohort, in which only 1373 (44.4%) patients had 
surgery at night (p = 0.007).  A total of five patients with AAGA (41.7%) had general anaesthesia after 
failed or inadequate neuraxial anaesthesia. This was not significantly different from the 861 (27.6%) 
in the non-AAGA group (p = 0.278). Processed electroencephalogram (pEEG) monitoring was low in 
 
 
the baseline cohort, used on only 148 (4.7%) patients across only seven hospital sites. No AAGA 
patients received pEEG monitoring. There were no cases of AAGA attributed to wrong drug 
administration or syringe swap events. A consultant was the most senior anaesthetist present in 
theatre for only three (25.0%) of the AAGA patients (although one consultant attended only after 
the AAGA event had occurred), but this was not significantly different to the proportion in the 
baseline cohort of 1216 (39.0%; p = 0.32). 
In the binary regression model, deviation from a healthy reference BMI of 18.5-25 kg.m-2 was 
significantly associated with AAGA; specifically, BMI <18.5 (OR 18.1; 95% CI 1.0 – 318.9; p = 0.048) 
and BMI 25-30 (OR 10.8; 95% CI 1.23 – 93.8; p = 0.031). Although infrequently used as the primary 
induction drug overall, ketamine was over-represented in AAGA cases (OR 186; 95% CI 9.1 – 3824; p 
= 0.001). Thiopental use (OR 3.5; 95% CI 0.7 – 16.7) and start of general anaesthesia during a night 
shift (OR 3.3; 95% CI 0.61 – 18.2) were both significantly associated in univariate testing and had 
higher odds ratio of AAGA, but were not statistically significant (p = 0.122 and p = 0.163 respectively) 
in binary regression. 
Table 4 provides abbreviated reports of each patient’s experience of AAGA and a narrative 
description of individual psychological implications during the 12-month postoperative follow-up 
period (detailed reports for each patient are provided in Supplementary materials Table S1). 
Distressing AAGA experiences, in which fear, suffocation or a sense of impending death were 
reported, occurred in seven (58.3%) patients (Figure 3). Paralysis was reported by five (41.7%) 
patients, of whom two (16.7%) reported paralysis in conjunction with pain. A further two (16.7%) 
patients reported pain as the only feature of their AAGA experience. Four (33.3%) patients reported 
isolated auditory or tactile perceptions. 
PCL-5 scores during postoperative follow up are provided in Figure 4 and 5. PCL-5 scores at 30 days 
postoperatively were significantly higher in the 12 certain/probable and possible AAGA patients 
(median (IQR [range]): 15 (2.75 – 52 [2 – 56]) than in the comparator cohort of 341 patients 
reporting no memories between “going to sleep” and “waking up” at the end of surgery: 3 (1 – 9 [0 – 
64]; p = 0.010). 
Four of the 12 AAGA patients (33.3%) met PCL-5 criteria for screening positive for PTSD (case IDs 1, 
4, 6 and 12); all of whom were referred for psychological support or mental health team review. A 
fifth participant (case ID 3) was marginally below the criteria (having only one, rather than the 
required two, significant symptom scores in the intrusion cluster) but scored a maximum total of 36 
 
 
points at 12 months following her surgery, above the threshold of 31-33 points indicative of 
probable PTSD. 
AGAA was significantly associated with screening positive for PTSD (OR 32.4; 95% CI 1.6 – 662; p = 
0.024); as was a diagnosis of postpartum depression (OR 25.4; 95% CI 2.4 – 274; p = 0.008). Other 
covariates in the regression model, including pre-term birth, history of depression, anxiety, PTSD and 
low birth weight, were not significant. Neither was self-perceived support from family or healthcare 
professionals, urgency of surgery or age. Four of the 341 (1.17%) patients in the non-AAGA 
comparator sample screened positive for PTSD, compared with four of the 12 patients (33.3%) in the 
AAGA group. The odds ratio of developing PTSD following AAGA, compared with non-AAGA controls 
was 42.1 (95% CI 8.9 – 199.1). 
Of the 12 patients with certain/probable or possible AAGA, seven (58.3%) were graded ≥1 on NPSA 
scores, indicating at least mild anxiety about future anaesthesia or intrusive psychological 
symptoms. Five patients (41.7%) were graded as 2 or 3, indicating moderate to severe anxiety about 
future anaesthesia or related healthcare, with symptoms having some impact on daily living. Due to 
withdrawal from follow up, NPSA grades could not be allocated for two patients (16.7%) with 
possible AAGA. 
 
Discussion 
The main finding of the study is that the incidence of AAGA in obstetrics, using direct questioning, is 
almost three times higher than previously ascertained when relying on patient self-reports: 1 in 256 
(95% CI 1 in 149 – 1 in 500) vs. 1 in 1200 (95% CI 1 in 714 – 1 in 2500) [2]. Both estimates are very 
much higher than the figure of 1 in 8000 reported for AAGA in the presence of NMB drugs for the 
general surgical population [2]. Almost two-thirds of the patients in our study described distressing 
experiences involving pain or paralysis during AAGA, and a third of patients with AAGA met 
screening criteria for PTSD during 12 months of postoperative follow-up. The odds ratio of 
developing post-natal PTSD after AAGA was very high, at 42, compared with non-AAGA controls. 
Previously Paech et al. (also using the Brice interview and similar adjudication criteria, but without a 
detailed verification phase or any follow up) reported an even higher incidence of 1 in 152 after CS 
[14]. However, the use of thiopentone was very much higher in 2009 (83% in Paech’s study vs. 52.9% 
in ours) and other changes in practice, perhaps informed by NAP5, may have reduced the incidence 
 
 
of obstetric AAGA somewhat. Intriguingly, the use of depth of anaesthesia monitors in the Paech et 
al. study was high (32% vs. 4.7% in our study), and this perhaps reflects its limited utility in 
preventing AAGA [22]. This limitation may also be because the majority of AAGA cases arise in the 
dynamic phases of anaesthesia (induction and emergence) when the interpretation of depth of 
anaesthesia monitors can be difficult (or they are not used in these phases). 
AAGA was a risk factor for PTSD, with AAGA patients having higher risk of developing PTSD and 
higher scores on the trauma symptomatology checklist. This finding extends previous research 
where nine of 16 (56.3%) people who had experienced AAGA met criteria for PTSD compared with 
zero of 10 non-AAGA controls [23]. These participants were recruited retrospectively and AAGA 
occurred a mean of 17.9 years before, so it is plausible that people with distressing AAGA 
experiences were over-represented. However, data from the B-Aware randomised trial by Leslie et 
al trial showed comparable risks with prospectively sampling [24]. AAGA cases were individually 
matched with non-AAGA controls. Five of seven AAGA cases (71%) met criteria for PTSD compared 
with three of 25 controls (12%). Our study confirms this serious risk of PTSD following AAGA in a 
prospective sample with a large control sample.  
It is noteworthy that AAGA emerged as a strong additional risk because childbirth is itself a risk 
factor for PTSD [18]. Meta-analysis estimates that between 0.9 and 4.6% of women develop PTSD 
after childbirth [18]; our figure of 1.17% for the non-AAGA patients falls towards the lower end of 
this range, despite the additional complication of general anaesthesia and surgery occurring in our 
sample. Known predictors of PTSD such as low social support, infant complications, and history of 
mental health problems [18], were not significant covariates in our study, but there was an 
association between PTSD and post-natal depression [25,26]. 
This study confirms the high incidence of AAGA in obstetrics identified in NAP5 and which persists 
despite putative changes in practice. Some patient risk factors are immutable, such as the higher 
incidence of obesity and the difficult airway in obstetrics [15]. Some practices are constrained, such 
as the need to use NMBs. Other practice changes have occurred, which we reported on recently 
[15]. The use of opioids appears possibly at least a little protective for AAGA (Figure 2). It is plausible 
that opioids and prior neuraxial block attenuate pain responses, e.g. even ‘failed’ neuraxial 
technique might provide some partial analgesia and therefore serves to obtund the arousal effects 
of higher intensity surgical pain, which otherwise leads to AAGA. Opioids have traditionally been 
avoided in obstetric general anaesthesia due to concerns regarding neonatal respiratory depression, 
although this rationale is not supported by current evidence [27]. 
 
 
The over-representation of thiopentone in the AAGA cases is striking (Figure 2). Our data suggests 
the risk of AAGA is increased four-fold by thiopentone vs. propofol; and 26-fold with use of ketamine 
vs. propofol. It has recently been suggested that, based on EEG recordings, propofol induction 
maintains deeper anaesthesia than thiopental in pregnant women [28], so there may be a 
pharmacological basis to our observations. Regardless, it would now seem prudent to have a specific 
justification for the use of thiopentone or ketamine as induction agents in obstetrics, rather than 
consider these agents as default choices. 
Our observation that night shift operations with predominantly trainee-led anaesthesia were a risk 
factor for AAGA presents a complex problem that requires careful consideration. Working pattern 
changes take time to implement and simply extending consultant hours or shifts may lead to other 
unintended consequences [29] or fail to improve outcomes. 
We encountered two patients who reported ‘AAGA’ but in fact had endured the complication of a 
total spinal (they were not included as part of the AAGA cohort). This highlights the reality that 
apparently unconscious patients can be fully aware of surroundings (akin to neuromuscular blockade 
without anaesthesia). While the focus of attention in this emergency scenario should be on 
cardiorespiratory resuscitation, it is also essential to ensure hypnosis to avoid potential 
psychological sequelae. Current recommendations are that hypnotic drugs should be given only as 
soon as the clinical situation permits [30], but analysis of these patients’ experiences suggests the 
two interventions – resuscitation and anaesthesia – should go hand in hand. 
Other possibilities, apart from practice issues, should be considered for the markedly increased 
incidence of AAGA in obstetrics. One is that childbirth is a time of heightened attention to 
surrounding events, such that brief episodes of AAGA may be magnified in recall, much as are 
perhaps other details of the birthing experience [31]. These experiences in the general surgical 
population without the heightened attention, such as revealed using the isolated forearm technique 
[32], might be regarded as trivial (termed dysanaesthesia [33,34]; a brain state in which uncoupling 
of perception from sensation results in a neutral experience, leaving patients unconcerned with any 
awareness). In this regard, it is notable that in fact, the majority of our cases were also early self-
reporters and that repeated Brice interviewing did not yield a higher estimated incidence. In other 
words, obstetric patients are more likely to make a report of AAGA, perhaps because of their 
heightened attention.  
Another possibility is that the hormonal changes associated with pregnancy influence memory, 
recall or even sensitivity to general anaesthesia, such as to increase the likelihood of AAGA. Although 
 
 
the minimum alveolar concentration (MAC) of volatile agents has been studied in animals and the 
first trimester of pregnancy in humans – and in both types of study shown in fact to be reduced as 
compared with non-pregnant females – it does not appear to have been studied in the third 
trimester. Uyema et al. report no effect of volatile anaesthetic sensitivity on electroencephalography 
in later stages of pregnancy, compared with non-pregnant matched controls undergoing general 
anaesthesia [35]. 
Our study clearly shows that simple administration of a Brice questionnaire alone is inadequate for 
accurate identification of AAGA, as it results in a misleadingly high incidence. The majority of 
‘positive Brice’ responses were, in fact reports of dreaming or memories outside the period of 
anaesthesia, and not AAGA. Therefore, at best, the Brice questionnaire should be viewed as a 
preliminary screening tool, perhaps something which prompts recall in the patient’s mind. 
Yet given that the incidence we identified appears higher than many other obstetric GA 
complications [36], there is a case to suggest that Brice questioning (one administration) should 
become routine follow up after general anaesthesia in obstetrics.  
Our data also have implications for seeking consent for general anaesthesia. The Montgomery ruling 
by the UK Supreme Court in 2015  concerned obstetric practice, and a complication that is arguably 
not greatly more frequent (1 in 136 [37]) than we now know from this study AAGA to be (1 in 254) 
[38]. Logically, it would seem incumbent upon anaesthetists to cite this risk of AAGA within the 
consent process for obstetric GA, as directed by the Supreme Court ruling. 
Whilst some cases of AAGA may have been preventable by the practice changes discussed above, 
others occurred in the absence of obvious deficiency of general anaesthetic drug delivery. A 
previously undiagnosed suxamethonium apnoea episode triggered one patient’s AAGA experience. 
Plasma pseudocholinesterase activity is known to fall rapidly during the first trimester and remain 
reduced for as long as into the immediate postpartum period [39]. This is of particular concern, 
given that nerve stimulator monitoring use was suboptimal in the baseline group [15]. 
It is important to acknowledge some methodological limitations to this study, some of which we 
have raised elsewhere [15,16], and many of which are common to all studies using the Brice 
interview. Administering this process involved two key steps – the patient interview followed by an 
adjudication process. The details of the latter can vary across studies [40], and therefore the rarity of 
AAGA events means that minor methodological inconsistencies within or between studies can 
influence the final result. We therefore employed the same adjudication structures as NAP5 and 
 
 
introduced the kappa score, which at least confirmed consistency within our adjudication panel 
(Table 2).  
Although 3115 patients completed the first Brice interview, only 1808 also completed the third; 42% 
were arguably ‘lost to follow up’ However, we used as our denominator the original 3115; i.e., our 
estimate of incidence is very conservative, and assumes that all these patients not followed up did 
not have AAGA memories. This is a safe assumption since we detected no new cases of AAGA with 
repeated Brice questioning. If even a small proportion of these lost-to-follow-up experienced AAGA, 
then our estimate of incidence would be very much higher than we report. Therefore, although we 
were disappointed not to follow up even more patients all the way to their third Brice interview, this 
does not affect our very striking result of a very high incidence of AAGA in obstetrics. 
Conclusions 
Action is needed to reduce the very high risk of AAGA in obstetrics that we report. National 
consensus guidelines would help ensure consistency of anaesthesia practice. With the incidence so 
high, and being associated with psychological harm in many patients, follow up and support for 
patients and staff is also necessary. The NAP5 psychological support pathway is a useful guide [19] 
but may need refinement for the obstetric setting. Attention should also focus on the process of 
seeking consent from a pregnant patient receiving general anaesthesia.  
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Tables 
 
Characteristics All patients (n = 3115) Patients reporting AAGA (n 
= 12) 
Patients   
Age; years 31.5 (6.1) 28.2 (5.7) 
Weight; kg 70 (60.8 – 84 [38 – 188]) 73.2 (64.0 – 78.2 [47 – 115]) 
BMI; kg.m−2 26.3 (22.7 – 31.1 [14.4 – 
80.4]) 
29.1 (25.7 – 30.4 [16.3 –  
44.9]) 
BMI ≥30; n (%) 737 (23.7%) 4 (25%) 
ASA PS ≥3; n (%) 504 (16.6%) 0 
Parity 
     1 
     2 
     3 
     ≥ 4 
     Unknown 
 
1842 (59.1%) 
724 (23.2%) 
290 (9.3%) 
214 (6.9%) 
45 (1.4%) 
 
7 (58.3%) 
3 (25%) 
2 (16.7%) 
0 
0 
Intraoperative   
Duration; minutes 60 (45 – 75 [6 – 390]) 64.5 (58.5 – 75 [55 – 105]) 
Start time 
     08:00 – 19:59 
     20:00 – 07:59 
 
1732 (55.6%) 
1383 (44.4%) 
 
2 (16.7%) 
10 (83.3%) 
Surgical procedures 
     CS 
     EUA 
     MROP 
     Other 
     Unknown 
 
2554 (81.9%) 
214 (6.4%) 
202 (5.3%) 
23 (4.1%) 
101 (3.2%) 
 
12 (100%) 
0 
0 
0 
0 
Urgency of surgery 
     Emergency / Category 1 
     Urgent / Category 2 
     Expedited / Category 3 
     Elective / Category 4 
     Unknown 
 
1636 (52.5%) 
815 (26.1%) 
178 (5.7%) 
387 (12.4%) 
101 (3.2%) 
 
3 (25.0%) 
8 (66.7%) 
0 
1 (8.3%) 
0 
Estimated blood loss; n (%) 
     <500ml 
     500-999ml 
     1000 – 1999ml 
     ≥2000ml 
     Unknown 
 
685 (22.0%) 
1192 (38.3%) 
740 (23.8%) 
437 (14.0%) 
61 (2.0%) 
 
4 (33.3%) 
5 (41.7%) 
2 (16.7%) 
1 (8.3%) 
0 
Experience of most senior attending 
anaesthetist; n (%) 
     Consultant 
     Staff grade or Associate Specialist 
     Higher/advanced trainee (ST5-7)      
     Intermediate trainee (ST3-4) 
     Junior trainee (CT1-2) 
     Unknown 
 
 
1216 (39.0%) 
670 (21.5%) 
501 (16.1%) 
494 (15.9%) 
105 (3.4%) 
129 (4.1%) 
 
 
3 (25.0%) 
2 (16.7%) 
3 (25.0%) 
4 (33.3%) 
0 
0 
 
 
Induction drug and dose; n (%), 
median (IQR [range]) mg.kg-1 
     Thiopental 
 
 
     Propofol 
 
 
     Ketamine 
 
 
1649 (52.9%) 
6.3 (5.2 – 7.3 [1.3 – 14.6]) 
 
1419 (45.5%) 
2.8 (2.3 – 3.3 [0.4 – 6.9]) 
 
28 (0.9%) 
2.1 (1.7 – 3.2 [1.5 – 4]) 
 
 
9 (75.0%) 
6.4 (5.1 – 8 [3.9 – 10.6] 
 
2 (16.7%) 
1.7 & 2.0 
 
1 (8.3%) 
2.4 
 
Table 1. Baseline patient and surgical characteristics for all patients and only patients reporting 
certain/probable AAGA. Values are mean (SD) or median (IQR [range]) or number (proportion). 
Weights were recorded at time of pregnancy booking appointment. ASA = American Society of 
Anesthesiologists’ Physical Status score. CS = caesarean section; EUA = Exploration under 
anaesthesia; MROP = manual removal of placenta. 
  
 
 
 
Adjudication panel outcome N Prevalence (95% CI) 
AAGA Total 12 1 in 256 (1 in 149 – 1 in 500) 
Certain/probable 7 1 in 455 (1 in 217 – 1 in 1111) 
Possible 5 1 in 625 (1 in 270 – 1 in 2000) 
No AAGA Unlikely 6 1 in 526 (1 in 238 – 1 in 1428) 
Awareness during non-GA 
circumstances 
     Awareness during total spinal 
     anaesthesia 
     Awareness during postoperative 
     sedation on intensive care unit 
4 
 
2 
 
2 
1 in 769 (1 in 303 – 1 in 3333) 
 
1 in 1666 (1 in 435 – 1 in 10,000) 
 
1 in 1666 (1 in 435 – 1 in 10,000) 
Dreaming 
     With content recall: 
 
          Pleasant 
          Neutral 
          Unpleasant 
167 
71* 
 
20 
35 
8 
1 in 19 (95% CI 1 in 16 – 1 in 22) 
1 in 44 (95% CI 1 in 35 – 1 in 56) 
 
28.2% 
49.3% 
11.2% 
Memories not during GA 71 N/A 
Insufficient 
evidence 
Unable to complete required 
verification assessment 
6 N/A 
 
Table 2. Adjudication outcomes of the likelihood of accidental awareness during general 
anaesthesia. A reported dream alone was not classified as awareness. *Eight patients reporting 
dreaming with content recall also described experiences consistent with AAGA; these patients were 
excluded from classification of dream emotional content.
 
 
ID Adjudication 
outcome 
Michigan 
Awareness 
Classification 
instrument 
Phase of 
anaesthesia 
Surgery Induction drug; 
dose (mg.kg-1) 
Opioid for 
induction 
NMB drug for 
tracheal 
intubation 
Add somewhere 
NMB moniitor 
Maintenance drug  
Nitrous oxide for 
maintenance 
Minimum alveolar 
concentration (MAC); 
median [range] 
Additional NMB drug 
NPSA Summary of experience by the 
patient 
 
1 Certain/ 
probable 
5D Induction & 
maintenance 
CS Cat 2 Thiopental (3.9) 
No opioid 
Suxamethonium 
Sevoflurane 
No nitrous oxide 
MAC 0.9 [0.7-1.0] 
No further NMB drug 
3 A detailed recollection of the 
process of tracheal intubation 
and felt a painful initial surgical 
incision. 
 
1.00 
2 Certain/ 
probable 
4D Emergence CS Cat 1 Thiopental (6.7) 
No opioid 
Suxamethonium 
Sevoflurane + nitrous 
oxide 
MAC 0.9 [0.8 – 1.2] 
No further NMB drug  
3 Residual paralysis during 
emergence. Confirmed 
suxamethonium apnoea. 
1.00 
3 Certain/ 
probable 
5D Maintenance CS Cat 2 Thiopental (4.7) 
Alfentanil 
Suxamethonium 
Sevoflurane + nitrous 
oxide 
MAC 1.4 [1.3 – 1.6] 
No further NMB drug 
2 Felt surgical pain and hearing 
voices asking for surgical 
instruments.  
1.00 
4 Certain/ 
probable 
4D Emergence CS Cat 2 Thiopental (10.6) 
Fentanyl 
Rocuronium 
Sevoflurane + nitrous 
oxide 
MAC 1.1 [1 – 1.2] 
No further NMB drug 
2 Residual paralysis during 
emergence, secondary to 
incomplete reversal of 
rocuronium. 
1.00 
5 Certain/ 
probable 
2 Induction CS Cat 1 Thiopental (8.0) 
No opioid 
Sevoflurane + nitrous 
oxide 
0 Painless sensation of the initial 
surgical incision. 
1.00 
 
 
Suxamethonium MAC 1.1 [1 – 1.2] 
Atracurium 
6 Certain/ 
probable 
4 Induction CS Cat 2 Propofol (1.7) 
No opioid 
Suxamethonium 
Sevoflurane 
No nitrous oxide 
MAC 1.1 [1.2 – 1.5] 
No further NMB drug 
2 Felt unable to move and heard 
multiple voices; likely occurred 
during management of difficult 
airway. 
1.00 
7 Certain/ 
probable 
4D Induction CS Cat 2 Thiopental (8.6) 
No opioid 
Suxamethonium 
Isoflurane + nitrous 
oxide 
MAC 1.1 [0.9 – 1.2] 
Atracurium 
1 Immediately after induction she 
experienced a dream-like 
sensation of falling into water, 
drowning and being unable to 
breath. 
0.33 
8 Possible 1 Other CS Cat 4 Thiopental (5.9) 
No opioid 
Suxamethonium 
Sevoflurane + nitrous 
oxide 
MAC 1.0 [0.8 – 1.2] 
Atracurium 
0 Heard female voices holding a 
conversation, but unable to 
independently corroborate as 
occurring intraoperatively. 
1.00 
9 Possible 3D Maintenance CS Cat 2 Thiopental (5.1) 
No opioid 
Suxamethonium 
Sevoflurane 
No nitrous oxide 
MAC 0.8 [0.6 – 0.9] 
No further NMB drug 
N/A Reported possible pain 
sensation whilst expecting to be 
unconscious, but inconsistent 
details. 
1.00 
10 Possible 2 Emergence CS Cat 1 Thiopental (6.4) 
No opioid 
Suxamethonium 
Sevoflurane 
No nitrous oxide 
MAC 1.0 [0.4 – 1.5] 
No further NMB drug 
0 Possible dissociative 
anaesthesia; reporting 
sensation of being out of her 
body. 
0.56 
11 Possible 3D Induction CS Cat 2 Ketamine (2.4) 
Alfentanil 
Suxamethonium 
Sevoflurane 
No nitrous oxide 
MAC 0.9 [0.7 – 1.0] 
N/A She felt a sting at the back of 
her throat shortly after 
induction. Possible dissociative 
anaesthesia; felt asleep but 
0.56 
 
 
No further NMB drug aware of what was happening, 
like in a dream. 
12 Possible 1 Emergence CS Cat 2 Propofol (2.0) 
Fentanyl 
Rocuronium 
Sevoflurane 
No nitrous oxide 
MAC 1.2 [1.1 – 1.3] 
No further NMB drug 
1 Hearing voices at an unspecified 
time point after induction, with 
little other detail. 
0.33 
 
Table 3. Grading of accidental awareness during general anaesthesia events according to panel adjudication of likelihood and Michigan Awareness 
Classification Instrument. Class 1 indicates isolated auditory perceptions; class 2, tactile perceptions (e.g., perception of surgical manipulation or 
endotracheal tube); class 3, pain; class 4, paralysis (e.g., a feeling that one cannot move, speak, or breathe); and class 5, paralysis and pain. An additional 
designation of “D” is applied where the report described distress during the experience (e.g. fear, suffocation, sense of impending death, etc.). Surgical and 
anaesthetic of participant surgical, anaesthetic and accidental awareness are summarised. Modified National Patient Safety Agency (NPSA) classification, 
summarises the psychological impact on the patient as: 0 = No harm occurred.  1 = Resolved (or likely to resolve) with no or minimal professional 
intervention; no consequences for daily living, minimal or no continuing anxiety about future healthcare. 2 = Moderate anxiety about future anaesthesia or 
related healthcare; symptoms may have some impact on daily living; patient has sought or would likely benefit from professional intervention. 3 = Striking 
or long-term psychological effects that have required, or might benefit from, professional intervention or treatment; severe anxiety about future healthcare 
and/or impact on daily living; recurrent nightmares or adverse thoughts or ideations about events. 4 = Caused death.  statistic indicates the measure of 
agreement of panel members on likelihood awareness classification, with a value of 1.0 representing unanimous agreement. 
  
 
 
ID Narrative description 
1 Patient: 32 y/o; BMI 27 kg.m-2. 
Clinical scenario: Failed epidural top-up for emergency CS. GA due to clinical urgency 
Induction: Thiopental 3.9mg.kg-1 and Suxamethonium. 
AAGA experience: Detailed, unpleasant memories of uncontrollable muscle spasm, intubation and pain of first incision. 
Follow-up: Anxiety and panic attacks several weeks later. High PTSD scores for 12 months. Required antidepressant therapy and community mental health 
team input. 
2 Patient: 30 y/o; BMI 28 kg.m-2. 
Clinical scenario: GA for fetal cord prolapse 
Induction: Thiopental 6.7mg.kg-1 and Suxamethonium. 
AAGA experience: Paralysis during emergence. Unable to breathe or move. Able to hear voices before being re-anaesthetised.  
Follow-up: Diagnosed with suxamethonium apnoea. PTSD scores initially low, rising at 6 months with anxiety symptoms. Patient required regular psychology 
consultations. 
3 Patient: 24 y/o; BMI 43 kg.m-2. 
Clinical scenario: GA for failed epidural top-up for emergency CS.  
Induction: Thiopental 4.7mg.kg-1, 1mg alfentanil and Suxamethonium. 
AAGA experience: Detailed recall of voices and of sharp cutting pain across her abdomen. Unable to communicate. 
Follow-up: Low PTSD scores but required counselling after difficulty sleeping and nightmares of the experience. 
4 Patient: 29 y/o; BMI 16 kg.m-2. 
Clinical scenario: Intra-operative conversion to GA after inadequate neuraxial block. 
Induction: Thiopental 10.6mg.kg-1, fentanyl 100mcg and rocuronium. 
AAGA experience: Recall of profound paralysis and throat obstruction at emergence. 
Follow-up: PTSD score high, reducing at 6 months. 
5 Patient: 42 y/o; BMI 20 kg.m-2. 
Clinical scenario: De novo GA due to clinical urgency. EBL >2L. 
Induction: Thiopental  8.0mg.kg-1 and suxamethonium. 
AAGA experience: Painless sensation of a cut across the abdomen, unable to communicate. 
Follow-up: Very low PTSD scores 
6 Patient: 27 y/o; BMI 45 kg.m-2. 
Clinical scenario: GA following failed epidural top-up and unsuccessful spinal for emergency CS.  
Induction: Propofol 1.7mg.kg-1 with suxamethonium. Difficult airway management with additional 100mg of propofol administered. 
AAGA experience: Recall of voices, but no distress or pain. 
Follow-up: High PTSD scores and subsequent mental health review. Diagnosed with postpartum depression 
7 Patient: 29 y/o; BMI 25 kg.m-2. 
Clinical scenario: GA following failed epidural top-up and unsuccessful spinal for emergency CS.  
Induction: Thiopental 8.6 mg.kg-1 with suxamethonium.  
 
 
AAGA experience: Recall of a feeling of suffocation and inability to breathe together with a drowning sensation on induction. 
Follow-up: Low PTSD scores. 
8 Patient: 31 y/o; BMI 30 kg.m-2. 
Clinical scenario: Elective GA  
Induction: Thiopental 5.9mg.kg-1 with suxamethonium. Two attempts at intubation. 
AAGA experience: Recall of female voices and specific conversations. 
Follow-up: Very low PTSD scores. 
9 Patient: 19 y/o; BMI 29 kg.m-2. 
Clinical scenario: Intra-operative conversion to GA after inadequate neuraxial block. 
Induction: Thiopental 5.1mg.kg-1 with suxamethonium.  
AAGA experience: Recall of pain in vagina and lower abdomen. Reported that she wasn’t fully asleep. 
Follow-up: Patient withdrew from follow up 
10 Patient: 29 y/o; BMI 27 kg.m-2. 
Clinical scenario: De novo GA due to clinical urgency. 
Induction: Thiopental 6.4mg.kg-1 with suxamethonium.  
AAGA experience: Describes a sensation of being out of her body, possible awareness during dissociative anaesthesia 
Follow-up: Patient withdrew from follow up. 
11 Patient: 23 y/o; BMI 31 kg.m-2. 
Clinical scenario: De novo GA due to clinical urgency. 
Induction: Ketamine 2.4mg.kg-1, 1mg alfentanil and suxamethonium followed by 2mg midazolam after 15 minutes. 
AAGA experience: Describes a disturbing sensation of a sting at the back of the throat accompanied by what she describes as a ‘déjà vu’ experience. 
Follow-up: Patient withdrew from follow up. 
12 Patient: 32 y/o; BMI 30 kg.m-2. 
Clinical scenario: GA following failed epidural top-up 
Induction: Propofol 2.0mg.kg-1, fentanyl 50mcg and suxamethonium.  
AAGA experience: The patient recalled hearing voices and felt that she was partly awake during surgery 
Follow-up:  High PTSD scores reducing over the course of 12 months. 
 
Table 4. Abbreviated narrative reports of accidental awareness during general anaesthesia experiences and postoperative follow up psychological 
outcomes. Detailed reports of patient experiences and follow up are provided in Supplementary materials, Table S1. CS = caesarean section delivery. 
 
 
Legends to figures 
 
Figure 1. STROBE flowchart of participant recruitment and outcome adjudications. Outcomes are 
stratified as accidental awareness during general anaesthesia (AAGA) and “No AAGA”, with “Unlikely 
AAGA” included in the latter category. A total of six patients had screening Brice interview responses 
indicating suspected awareness during general anaesthesia, however verification assessment was 
not able to be completed, hence insufficient evidence was available to adjudicate these reports 
using equivalent criteria to the remaining cases. 
 
Figure 2. Comparison of the prevalence of characteristics in patients with certain/probable and 
possible accidental awareness during general anaesthesia (grey bars; n = 12) with baseline values for 
the whole cohort (dot and line; n = 3115). Thiopental use and general anaesthesia during the night 
shift (20:00-07:59) are over-represented in the accidental awareness group, whilst opioid use during 
induction of general anaesthesia is under-represented, for example. NMB drug = neuromuscular 
blocking drug. De novo GA indication general anaesthesia provided prior to the initial surgical 
incision (the remainder were conversions from neuraxial anaesthesia). 
 
Figure 3. Hierarchical representation of Michigan Awareness Classifications for AAGA patients (n = 
12), showing that immediate distress occurring exclusively in patients reporting pain and/or paralysis 
(affecting almost all patients reports those experiences). None of the four patients who reported 
auditory or tactile perceptions had distress. 
 
Figure 4. PCL-5 scores at 30 days postoperatively for patients with certain/probable and possible 
accidental awareness during general anaesthesia (n = 12), compared with baseline (n = 341). Solid 
line = median; box = IQR; whisker = upper and lower adjacent values.  
 
Figure 5. Psychological outcomes for each participant measured using PCL-5 scores. Each chart 
corresponds to a participant ID, with the Michigan Awareness Classification provided in parentheses 
(“D” designation is applied where the report described distress during the experience). The panels 
are arranged so that the higher Michigan classes are at the top, and the lower at the bottom.  PCL-5 
scores are grouped and labelled according to symptom clusters, as avoidance or intrusion symptoms 
etc. A PCL-5 score of between 31-33 is indicative of probable post-traumatic stress disorder. 
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Supplementary materials 
 
ID Narrative description 
1 32 year old woman with a BMI of 27 kg.m2. The patient had never had a GA previously and had no 
significant medical history. Induction of anaesthesia began during the early morning (6am) for CS, with 
anaesthetic care provided by an intermediate trainee. An epidural bolus was administered, but there 
was inadequate sensory block on testing prior to the start of surgery. A de novo GA was chosen 
instead of spinal anaesthesia due to clinical urgency. Induction drugs provided were 300mg (3.9mg.kg-
1) thiopental and no opioids. She received suxamethonium for tracheal intubation. There was no 
airway management difficulty and surgery was otherwise uneventful. 
The patient had detailed unpleasant memories of intubation, including feeling her head and neck 
being involuntarily tilted backwards, uncontrollable muscle spasm (presumably following 
administration of suxamethonium) and sensation of a tube being passed into the back of her mouth 
then deep into her throat. She experienced sharp pain of the initial surgical incision and being unable 
to move or communicate. The episode seemed to her to last 5-10 minutes. 
The patient initially reported her experiences to her partner, who raised doubts about their credibility. 
As a consequence, she only reported the experience on her second Brice interview. Following her 
medical debrief the patient was referred for external counselling and follow up with her local 
maternity mental health team. Four weeks postpartum, she began to experience anxiety episodes and 
panic attacks. She had recurrent intrusive memories of her awareness experience triggered by non-
threatening occurrences, including use of a throat spray leading to vivid recall of the intubation. 
Attendance within medical environments also led to physical avoidance symptoms. 
PTSD scores were high and remained relatively static throughout 12 months of follow up. She was 
prescribed an antidepressant and received community mental health team care. A local investigation 
concluded that inadvertent antibiotic administration during induction of anaesthesia was unlikely. 
2 30 year old woman with a BMI of 28 kg.m2. The patient had a history of previous GAs for ovarian cyst 
surgery with no reported complications. Emergency (Category 1) presentation for a CS in the evening 
(8pm) with an umbilical cord prolapse at 24 weeks gestation. Induction of GA was provided with 
500mg (6.7mg.kg-1) thiopental, no opioids and suxamethonium. A grade 2b direct laryngoscopy view 
was obtained, but tracheal intubation was not difficult. The neonate was delivered and taken to 
neonatal intensive care.  
The patient described residual paralysis during emergence. She recalled waking and not being able to 
breath or move, and hearing multiple voices using medical terminology. She did not feel any pain. She 
then remembers an abrupt loss of consciousness before waking again in the intensive care unit. 
A consultant anaesthetist was called after emergence, and use of a nerve stimulator only at this stage 
confirmed residual paralysis and a suspected diagnosis of suxamethonium apnoea; sevoflurane was 
re-administered. The patient was commenced on an intravenous propofol infusion (unclear if target 
controlled infusion mode or not) and transferred to the intensive care unit, where she was sedated for 
15 hours, before being extubated uneventfully. Later serological testing confirmed an abnormal 
cholinesterase phenotype. 
The patients initially reported low PCL-5 scores, but these increased at 6 months, with mild anxiety 
symptoms and a recurrent sense of claustrophobia. She began regular psychologist consultations. 
3 24 year old woman with a BMI 43 kg.m2, history of fibromyalgia, bipolar disorder and a previous 
uneventful GA. A decision for CS was made overnight (12am) due to failure of labour progression and 
concerns regarding fetal distress. The patient had an existing epidural catheter but demonstrated 
persistent light touch sensation after the first epidural top up bolus, resolving after a second epidural 
dose. Surgery commenced but the patient felt pain during the initial surgical incision. Surgery was 
stopped immediately, and the anaesthesia converted to GA. Induction of GA was with 500mg (4.7 
mg.kg-1) thiopental, 1mg alfentanil and suxamethonium; intubation occurred with grade 1 
laryngoscopy, anaesthesia lasted 80 minutes and surgery was otherwise uneventful. 
The patient had detailed chronological recall of initial loss of consciousness, later followed by hearing 
female voices asking for various surgical instruments. She felt a sharp, distressing, cutting pain across 
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her abdomen, lasting approximately 10 mins, before she gradually lost consciousness again. She tried, 
but was unable, to open her eyes or communicate. The patient remembered these events 
immediately after waking but was initially unsure if the experience was normal. 
The patient had intrusive symptoms, difficulty sleeping and nightmares of the experience. After 
medical debriefing she was referred to counselling services. Her PCL-5 scores were otherwise generally 
low, and she withdrew from further follow up at 6 months. 
4 29 year old woman with a BMI of 16 kg.m2. She reported a history of a previous uneventful GA. CS 
surgery took place overnight (2am), following conversion of failed regional anaesthesia to GA, due to 
breakthrough pain after the neonate was delivered. Induction was with 500mg (10.6 mg.kg-1) 
thiopental and 100mcg fentanyl, with no airway difficulties. She received rocuronium as the NMDB for 
tracheal intubation. Both neostigmine and sugammadex were administered during emergence due to 
concern regarding inadequate reversal of neuromuscular blockade. No nerve stimulator was used. The 
patient had a background history of previous GAs for dental surgery and well controlled bipolar 
disorder, requiring no regular pharmacological therapy during pregnancy. 
The patient immediately and spontaneously reported recall of specific intra-operative events to 
recovery nursing staff. She remembered waking feeling profoundly paralysed, unable to breath, an 
obstruction in her throat and a sense that she was going to die. She felt the experience lasted only 1-2 
minutes and later remembered being no longer paralysed, followed by a less distressing experience of 
the endotracheal tube being removed during emergence. 
She received multiple medical debrief consultations then later declined further offers of counselling. 
Her pre-term baby received ongoing paediatric input for possible development delay. Her PCL-5 scores 
were high, then reduced progressively from 6 months onwards. Of note she reported a previous 
history of parasomnias, including occasional nocturnal sleep paralysis. 
5 42 year old woman with no prior medical history and BMI of 20 kg.m2.  She received a de novo GA (her 
first GA) for a Category 1 CS overnight (3am); induction with 450mg (8.0 mg.kg-1) thiopental, no 
opioids and suxamethonium. There were no anaesthetic difficulties identified by the higher/advanced 
anaesthetic trainee, but there was extensive bleeding during surgery (EBL >2L) and a prolonged 
surgery time of 105 mins. 
The patient had memories, triggered by the first interview, of the induction phase of anaesthesia, 
during which she recalled feeling persistently drowsy but not unconscious. For a few seconds, 
occurring clearly before loss of consciousness, she recalled a painless sensation of being cut across her 
abdomen. She immediately tried to communicate, but was unable to do so, then couldn’t feel 
anything else. She had no further recall and was not distressed. 
The patient had no adverse sequalae, did not require further psychological input after initial debriefing 
and had very low PCL-5 scores, despite risk factors for postpartum PTSD (including pre-term neonatal 
birth requiring neonatal intensive care unit admission). She had no fear regarding future anaesthesia. 
6 27 year old woman with a high BMI (45 kg.m2), history of depression and anxiety trait. No previous 
surgery or GA. Underwent a difficult anaesthetic for a Category 2 CS during the late evening (10pm) by 
an intermediate trainee. The initial epidural top-up failed to achieve an adequate sensory block, hence 
a spinal anaesthetic was attempted. The spinal anaesthetic was difficult, and the intrathecal space 
could not be identified. A GA was therefore administered with an induction dose of 200mg propofol 
(1.7 mg.kg-1) and suxamethonium as the NMB drug. Unfortunately, airway management was 
challenging; the first attempt to intubate the tracheal was unsuccessful. Ventilation via bag-mask was 
inadequate, as were attempts to oxygenation via a second generation supraglottic airway device (Igel). 
A second attempt to intubate the trachea with a McGrath videolaryngoscope was subsequently 
successful. Pulse oxygen saturations fell to 30% at the lowest; there was no bradycardia or loss of 
cardiac output. The second intubation attempt was preceded by an additional dose of 100mg 
propofol, but no further NMB drug. After tracheal intubation and ventilation there was a rapid rise in 
oxygen saturations to 98%. The duration of airway management was reported as 3-4 minutes. There 
were no other intraoperative difficulties and surgical blood loss was minimal. 
The patient heard several voices speaking, but could remember any distinctive words or phrases 
spoken, nor could she identify or recognise the voices. She felt paralysed, but relaxed and calm. She 
didn’t recall any pain or other physical sensations. She described the experience as dream-like, as 
though the voices were distant and a feeling of shadows or presence around her that she couldn’t see. 
Although she initially denied pain or distress, she scored high on subsequent PCL-5 follow up and 
received mental health team review. She was diagnosed with postpartum depression for this 
pregnancy. She felt uneasy, but otherwise undeterred, at the prospect of future anaesthesia. 
7 29 year old woman with no prior medical history and BMI of 25 kg.m2. She underwent a GA at 6am 
with 500mg (8.6mg.kg-1) thiopental, no opioids and suxamethonium; there were no anaesthetic or 
surgical complications. She had no prior surgical or GA history. 
The patient initially described her experience as being like an unpleasant dream, in which after 
administration of the induction drugs she felt immediately suffocated as she fell deeper into a pool of 
clear water. She reported being unable to breath, but described no sound, pain or other physical 
sensations. The experience was likened to drowning and lasted less than one minute. This experience 
was reported despite sufficient total induction dose of thiopental, although the exact timing and detail 
regarding sequence of NMB and induction drug were not clear. 
Despite the distressing experience, the patient had no adverse sequalae, did not require further 
psychological input after initial debriefing and had low PCL-5 scores. This description has time features 
and is consistent with descriptions of paralysis associated with suxamethonium. 
8 31 year old woman, with a prior history of sexual assault as teenager, during which she was given a 
drug that reportedly rendered her temporarily immobile. She was subsequently diagnosed with PTSD. 
She had a history of multiple previous GAs, including her two previous LSCS, which had been 
conducted electively with GA due to maternal anxiety regarding lack of movement of her legs during 
spinal anaesthesia. She had a BMI of 30 kg.m2. 
This LSCS was scheduled as elective, for the above reasons. Induction of GA commenced at 10am with 
consultant supervision. Thiopental 425mg (5.9mg.kg-1) was administered, with no opioid and 
suxamethonium. The GA involved two intubation attempts: the first by a junior trainee and second by 
a consultant, during which the direct laryngoscopy view was grade 1. No further intravenous induction 
drug was administered. There were no other surgical or anaesthetic complications. 
The patient remembers hearing female voices only, including memories of specific conversations, 
which were not corroborated as having occurred intraoperatively. There was no indication that she 
felt paralysis, pain or any other physical sensation. Whilst surprised and confused by the experience, 
she denied any distress. She is convinced that what she remembers wasn't normal and that it did not 
align with her previous GA experiences, but was very accepting and didn't request any further support 
or intervention. 
9 19 year old women with a BMI of 29 kg.m2 and no prior medical history or previous GA. This patient 
had a poorly functioning epidural with unilateral block, with breakthrough contraction pain during 
labour. She was taken to theatre at 5am with failure to progress in labour for a category 2 CS. The 
epidural was topped up to provided regional anaesthesia and the neonate was safely delivered, 
despite a degree of surgical pain being experienced. This occurred at the insistence of the patient, who 
wanted to see her baby delivered whilst awake. General anaesthesia was then promptly provided, 
with a dose of 375mg thiopental (5.1 mg.kg-1), no opioid and suxamethonium. 
The patient was fixated on pain experience during the whole labour and surgical process and found it 
difficult to focus on recall of specific elements during the operative phase. She however repeatedly 
referenced feeling as though she wasn't "fully asleep" and could still feel pain. She described two 
phases to her general anaesthesia; the first during induction, then a distinct second phase during 
which she thought everyone expected that she was asleep, but she was still conscious. She 
remembered feeling pain in her vagina and lower abdomen during this time - the same feeling pain as 
during the earlier, pre-GA, phase of surgery. 
The participant withdrew from subsequent follow up, hence no PCL-5 results were collected. 
10 29 year old woman with a BMI of 27 kg.m2 and no prior medical history or previous GA. Cat 1 de novo 
GA for clinical urgency at 12pm. 450mg (6.4 mg.kg-1) thiopental was administered. She had no opioids 
and suxamethonium was used as the NMB drug for tracheal intubation. 
The patient lady gave slightly different accounts of reported intra-operative memories between 
interviews. All were described as being like dream-state, variably as though she were “flying in the 
sky” or that her “soul was out of her body”. She was adjudicated to have awareness associated with 
possible dissociative anaesthesia. 
11 23 year old woman with a raised BMI (31 kg.m2), but no prior medical history (or previous GA) and 
received a de novo GA for clinical urgency overnight (at 1am). 200mg (2.4mg.kg-1) ketamine,1mg 
alfentanil and suxamethonium were given by an associate specialist anaesthetist. The anaesthetist 
also provided 2mg of midazolam to the participant 15 minutes after induction of general anaesthesia. 
The patient provided an undetailed report but clearly described feeling a sting at the back of her 
throat. She considered the experience to be like “déjà vu”, or as though events were happened to her 
in a dream state. She found the experience disturbing. 
The experience was considered to be possible awareness during dissociative anaesthesia. The 
participant withdrew from subsequent follow up, hence no PCL-5 scores were collected. 
12 32 year old woman with a raised BMI (30 kg.m2), no other medical history and no previous GAs. She 
underwent a conversion to GA for a failed regional epidural top up due to retained movement and 
sensation on her left side. Induction of GA occurred at 11pm, prior to surgical start and involved 
administration of propofol 200mg (2.0 mg.kg-1), 50mcg fentanyl and rocuronium. There were no 
airway difficulties. Estimated blood loss during surgery was between 1-2L. 
The patient gave an account of possibly hearing voices at an unspecified time point after induction, 
with little other detail. She felt that she may have become partly awake during the surgery, but didn’t 
remember any pain, any difficulty breathing or any further detail. She reported her experience 
immediately post-operatively to her husband, who was an anaesthetic registrar. 
The patient received detailed debrief from clinical team. She had high intrusion symptom cluster 
scoring on PCL-5, which reduced progressively throughout 12 months follow up. She had moderate 
anxiety about the prospect of future general anaesthesia. 
 
Table S1. Full narrative reports of accidental awareness during general anaesthesia experiences and 
postoperative follow up psychological outcomes. CS = caesarean section delivery. 
